Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Background: Several clinical factors have been studied to predict atrial fibrillation (AF) recurrence after electrical cardioversion (ECV) with limited predictive value. Methods: A method able to ...

Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has been awarded a $3 million National Institutes of Health (NIH) Phase IIb SBIR grant for the development of an implantable, low-energy therapy for the ...

Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, shock polarity, ...

PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...